Literature DB >> 25503133

Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.

Claudia Umbreit1, Julia Flanjak2, Christel Weiss3, Philipp Erben4, Christoph Aderhold2, Anne Faber2, Jens Stern-Straeter2, Karl Hoermann2, Johannes David Schultz2.   

Abstract

BACKGROUND: The epithelial-mesenchymal transition (EMT) is suggested to be a crucial factor for the development of an invasive and metastatic cell phenotype, which is characterized by down-regulation of epithelial adhesive proteins (e.g. E-cadherin) and induction of mesenchymal proteins (e.g. vimentin). Therefore, there is a great clinical interest to specify this phenotype. Different growth factors induce EMT, such as epithelial growth factor (EGF) and transforming growth factor beta 1 (TGFβ1). The role of EMT in human papilloma virus (HPV)-positive squamous cell carcinoma (SCC) is still not understood. The aim of this study was to investigate the expression pattern in p16-positive and -negative SCC cells of vimentin, β-catenin and E-cadherin after stimulation with growth factors.
MATERIALS AND METHODS: We incubated the p16-positive CERV196 and p16-negative HNSCC22B SCC cell lines with EGF and EGF/TGFβ1 (10 ng/ml) and detected E-cadherin, vimentin and β-catenin by immunocytochemistry and enzyme-linked immunosorbent assay after 5, 24 and 96 h.
RESULTS: We found a low expression of vimentin in all studied tumor cell lines. The negative control of HNSCC22B cells showed a higher intrinsic level of membranous E-cadherin and β-catenin. We found statistically significant EGF/TGFβ1-induced expression of vimentin dependent on incubation time in p16-negative HNSCC22B cells. Particularly in the presence of EGF, we detected an increase of β-catenin and vimentin expression in p16-positive SCC tumor cell lines in addition to induced cell scattering and unexpected expression of E-cadherin.
CONCLUSION: In conclusion, E-cadherin, β-catenin and vimentin expression are important features to characterize EMT-like events. We were able to show incomplete EGF-induced EMT with β-catenin expression in p16-positive SCC. Extended studies are required to investigate the mechanistic role of EMT markers, especially in p16-positive SCC, in order to develop new anti-SCC therapies to block EMT progression. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  E-cadherin; ECM; EGF; EMT; Epithelial growth factor; HNSCC; HPV; SCC; TGFβ1; epithelial–mesenchymal transition; extracellular matrix; head and neck squamous cell carcinoma; human papillomavirus; p16-positive SCC; squamous cell cancer; transforming growth factor β1; vimentin; β-catenin

Mesh:

Substances:

Year:  2014        PMID: 25503133

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  How apoptosis and epithelial-to-mesenchymal transition are nested in EGFR inhibitors resistance in lung cancer.

Authors:  Simon Garinet; Audrey Didelot; Elena Garelli; Karine Pallier; Hélène Blons; Antoine Legras
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

2.  Effect of epithelial growth factor on matrix metalloproteinase-2 and E-cadherin/β-catenin expression in an in situ model of tumorigenesis.

Authors:  Natalia Festugatto Navarini; Vera Cavalcanti De Araújo; Marcelo Sperandio; Marcelo Henrique Napimoga; Lucas Novaes Teixeira; Ney Soares De Araújo; Elizabeth Ferreira Martinez
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

3.  Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells.

Authors:  Eun-Hui Jeong; Tae-Gul Lee; Yun Jung Ko; Seo Yun Kim; Hye-Ryoun Kim; Hyunggee Kim; Cheol Hyeon Kim
Journal:  Cell Oncol (Dordr)       Date:  2018-09-03       Impact factor: 6.730

Review 4.  Tumor Budding: The Name is EMT. Partial EMT.

Authors:  Alexandru Dan Grigore; Mohit Kumar Jolly; Dongya Jia; Mary C Farach-Carson; Herbert Levine
Journal:  J Clin Med       Date:  2016-04-29       Impact factor: 4.241

5.  Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study.

Authors:  Marine Lefevre; Alexandra Rousseau; Thomas Rayon; Véronique Dalstein; Christine Clavel; Agnès Beby-Defaux; Jean-Luc Pretet; Patrick Soussan; Myriam Polette; Jean Lacau Saint Guily; Philippe Birembaut
Journal:  Br J Cancer       Date:  2017-01-10       Impact factor: 7.640

6.  Stability of the hybrid epithelial/mesenchymal phenotype.

Authors:  Mohit Kumar Jolly; Satyendra C Tripathi; Dongya Jia; Steven M Mooney; Muge Celiktas; Samir M Hanash; Sendurai A Mani; Kenneth J Pienta; Eshel Ben-Jacob; Herbert Levine
Journal:  Oncotarget       Date:  2016-05-10

Review 7.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis.

Authors:  Mohit Kumar Jolly; Marcelo Boareto; Bin Huang; Dongya Jia; Mingyang Lu; Eshel Ben-Jacob; José N Onuchic; Herbert Levine
Journal:  Front Oncol       Date:  2015-07-20       Impact factor: 6.244

8.  Lapatinib-induced mesenchymal-epithelial transition in squamous cell carcinoma cells correlates with unexpected alteration of β-catenin expression.

Authors:  Claudia Umbreit; Philipp Erben; Anne Faber; Ralf-Dieter Hofheinz; Johannes David Schultz; Karl Hoermann; Angela Wenzel
Journal:  Oncol Lett       Date:  2016-03-01       Impact factor: 2.967

9.  Poly I:C induces collective migration of HaCaT keratinocytes via IL-8.

Authors:  Kazuhide Takada; Shihoko Komine-Aizawa; Naoko Hirohata; Quang Duy Trinh; Atsuyoshi Nishina; Hirokazu Kimura; Satoshi Hayakawa
Journal:  BMC Immunol       Date:  2017-04-24       Impact factor: 3.615

10.  TULP3: A potential biomarker in colorectal cancer?

Authors:  Ivaine Taís Sauthier Sartor; Mariana Recamonde-Mendoza; Patricia Ashton-Prolla
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.